XXD-47703-94654
3 vaccinations
3 coded responses
12 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 547 / WI
- Registered
- 2021-01-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2021-01-08
Registered in v-safe
-
2021-01-08
Dose 2 — Pfizer-BioNTech
-
2021-01-08
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Chills, Muscle or body achesAdult check-in
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities1 call case(s)
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-10
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
-
2021-01-22
Survey response — day 14, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: health condition - positive over the counter and doctor's office pregnancy testMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-29
Survey response — day 21, dose 2MedDRA: Pregnancy — Feeling: FairFree text: pregnantMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-09
-
2021-09-20
Dose 3 — Pfizer-BioNTech
-
2021-09-28
Survey response — day 7, dose 3MedDRA: Headache, Myalgia, Pain — Feeling: GoodFree text: 24 hours after dose experienced headache and muscle/body achesMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-09-20 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-09 | priority 2/3 | |
| 2021-01-10 | priority 2/3 |
Free text
Release 2 — day 14, dose 2
Symptoms: health condition - positive over the counter and doctor's office pregnancy test
Release 3 — day 21, dose 2
Symptoms: pregnant
Release 9 — day 7, dose 3
Systemic reaction (other): 24 hours after dose experienced headache and muscle/body aches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | ✓ | ✓ | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Myalgia | · | · | ✓ |
| SRO | Pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release